Jim Mellon

About Jim Mellon

Jim Mellon is an entrepreneur and investor with interests in several sectors. He holds a Master’s degree from Oxford in Politics, Philosophy, and Economics. From the mid 1980s, he worked as a fund manager in Asia and later in the United States until founding his own company in 1991. Jim is the co-chairman of Regent Pacific Group Limited, chairman of Manx Financial Group plc, chairman of Plethora Solutions Holdings plc, and chairman of Port Erin Biopharma Investments Limited. Jim has been in the top 10% in the Sunday Times Rich List for several years and is the chairman of FastForward Innovations. He is the chairman of his private company, Burnbrae Group Limited, which has significant investments in the life sciences, financial services, computer reselling, e-gaming, and leisure sectors. Jim spends considerable time evaluating different startup ideas and providing professional advice to people willing to invest in the most promising areas. He is also the co-author of four books: Wake Up!, The Top 10 Investments for the Next Ten Years, Fast Forward, and Cracking the Code. His most recent book, Juvenescence, is about biotech investment, and what he believes will be the coming biopharma revolution in longevity research.

Related Organizations

Related News

April 07, 2021

Jim Mellon’s Funding of Longevity Projects

How does an idea that is too unconventional for mainstream channels get funded? Often, even venture capitalist firms are too risk-averse, and government funding agencies are too entrenched in the status quo, to consider the most revolutionary ideas. Commonly given advice in the start-up world tells us to first look to the three F's: family,...

October 05, 2020

More Investors Are Becoming Interested in Longevity

More and more investors are starting to get interested in technologies that are being developed to slow or even reverse aging as therapies are starting to reach human trials. Recently, I attended the Longevity Investors Conference to learn more about investments being made towards anti-aging research. A shift towards doing something about aging The current...

May 18, 2020

Jim Mellon Donates £1 Million to Aging Research

Investment mogul Jim Mellon has donated a record-breaking 1 million British pounds to Oriel College in the United Kingdom, offering a ray of light for aging research. Supporting fundamental research on aging In recent years, one of the real dynamos of our community has been British investor and philanthropist Jim Mellon. Jim is perhaps best...

September 29, 2017

Juvenescence: Investing in the Age of Longevity

Jim Mellon and Al Chalabi are back with another successful venture into the world of science investment. Following their acclaimed 2012 book “Cracking the code”, whose spotlight was on the life sciences industry, Juvenescence takes us on a compelling journey through the dawning market of longevity and rejuvenation biotechnology, which the authors predict will be...

September 27, 2017

Review of Juvenescence: Investing in the Age of Longevity

Only two years ago, when I launched my advocacy website Rejuvenaction, I didn’t think I would read a book like Juvenescence so soon; yet, the topic of rejuvenation biotechnologies has already become mainstream enough to lead investors of the calibre of Jim Mellon and Al Chalabi to devote a whole book to it. As Juvenescence...

September 18, 2017

Investing in the Age of Longevity

Today, we are pleased to announce the imminent arrival of Jim Mellon and Al Chalabi's new book Juvenescence, which covers the field of rejuvenation biotechnology. The book focuses on technologies that will soon arrive, therapies that may increase healthy lifespan, and guidance for investors. The book offers a comprehensive overview of aging research and how...